ETRAElectra Therapeutics, Inc.
- Market cap
- $546.70M
- as of 2026-10-23
- Latest close
- $8.71
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
2 insiders bought $40.00M between Sep 21.
Under the default rule (14d · ≥2 insiders · all roles).
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | Holding change | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Gordon Carl L | Sep 21 | Sep 23 | P | 333,333 | $15.00 | Purchase +$4,999,995 | 5,126,891 | +7.0% | No | Form 4 |
| Gordon Carl L | Sep 21 | Sep 23 | P | 1,000,000 | $15.00 | Purchase +$15,000,000 | 1,758,279 | +131.9% | No | Form 4 |
| Orbimed Advisors LLC | Sep 21 | Sep 23 | P | 333,333 | $15.00 | Purchase +$4,999,995 | 5,126,891 | +7.0% | No | Form 4 |
| Orbimed Advisors LLC | Sep 21 | Sep 23 | P | 1,000,000 | $15.00 | Purchase +$15,000,000 | 1,758,279 | +131.9% | No | Form 4 |
Form 4 historysince 2026-09-21
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| OrbiMed Capital GP VII LLC | Sep 21 | Sep 23 | C | 2,002,310 | not reported | not reported | 2,002,310 | No | Form 4 |
| OrbiMed Capital GP VII LLC | Sep 21 | Sep 23 | C | 1,087,934 | not reported | not reported | 3,090,244 | No | Form 4 |
| OrbiMed Capital GP VII LLC | Sep 21 | Sep 23 | C | 1,703,314 | not reported | not reported | 4,793,558 | No | Form 4 |
| OrbiMed Capital GP VII LLC | Sep 21 | Sep 23 | P | 333,333 | $15.00 | Purchase +$4,999,995 | 5,126,891 | No | Form 4 |
| OrbiMed Capital GP VII LLC | Sep 21 | Sep 23 | C | 758,279 | not reported | not reported | 758,279 | No | Form 4 |
| OrbiMed Capital GP VII LLC | Sep 21 | Sep 23 | P | 1,000,000 | $15.00 | Purchase +$15,000,000 | 1,758,279 | No | Form 4 |
| OrbiMed Capital GP VII LLC | Sep 21 | Sep 23 | C · derivative | 2,002,310 | $0.00 | $0 | not reported | No | Form 4 |
| OrbiMed Capital GP VII LLC | Sep 21 | Sep 23 | C · derivative | 1,087,934 | $0.00 | $0 | not reported | No | Form 4 |
| OrbiMed Capital GP VII LLC | Sep 21 | Sep 23 | C · derivative | 1,703,314 | $0.00 | $0 | not reported | No | Form 4 |
| OrbiMed Capital GP VII LLC | Sep 21 | Sep 23 | C · derivative | 758,279 | $0.00 | $0 | not reported | No | Form 4 |
| Gordon Carl L | Sep 21 | Sep 23 | C | 2,002,310 | not reported | not reported | 2,002,310 | No | Form 4 |
| Gordon Carl L | Sep 21 | Sep 23 | C | 1,087,934 | not reported | not reported | 3,090,244 | No | Form 4 |
| Gordon Carl L | Sep 21 | Sep 23 | C | 1,703,314 | not reported | not reported | 4,793,558 | No | Form 4 |
| Gordon Carl L | Sep 21 | Sep 23 | P | 333,333 | $15.00 | Purchase +$4,999,995 | 5,126,891 | No | Form 4 |
| Gordon Carl L | Sep 21 | Sep 23 | C | 758,279 | not reported | not reported | 758,279 | No | Form 4 |
| Gordon Carl L | Sep 21 | Sep 23 | P | 1,000,000 | $15.00 | Purchase +$15,000,000 | 1,758,279 | No | Form 4 |
| Gordon Carl L | Sep 21 | Sep 23 | C · derivative | 2,002,310 | $0.00 | $0 | not reported | No | Form 4 |
| Gordon Carl L | Sep 21 | Sep 23 | C · derivative | 1,087,934 | $0.00 | $0 | not reported | No | Form 4 |
| Gordon Carl L | Sep 21 | Sep 23 | C · derivative | 1,703,314 | $0.00 | $0 | not reported | No | Form 4 |
| Gordon Carl L | Sep 21 | Sep 23 | C · derivative | 758,279 | $0.00 | $0 | not reported | No | Form 4 |
| Stagliano Nancy | Sep 21 | Sep 21 | C | 255,635 | not reported | not reported | 255,635 | No | Form 4 |
| Stagliano Nancy | Sep 21 | Sep 21 | C · derivative | 255,635 | not reported | not reported | not reported | No | Form 4 |
| Dong Quehuong (Kathy)President & CEO | Sep 21 | Sep 21 | C | 455,484 | not reported | not reported | 455,484 | No | Form 4 |
| Dong Quehuong (Kathy)President & CEO | Sep 21 | Sep 21 | C · derivative | 455,484 | not reported | not reported | not reported | No | Form 4 |
| Koe Gary S.Chief Technical Officer | Sep 21 | Sep 21 | C | 63,656 | not reported | not reported | 63,656 | No | Form 4 |
| Koe Gary S.Chief Technical Officer | Sep 21 | Sep 21 | C · derivative | 63,656 | not reported | not reported | not reported | No | Form 4 |
| Parry GrahamChief Scientific Officer | Sep 21 | Sep 21 | C | 85,504 | not reported | not reported | 85,504 | No | Form 4 |
| Parry GrahamChief Scientific Officer | Sep 21 | Sep 21 | C · derivative | 85,504 | not reported | not reported | not reported | No | Form 4 |